Therapeutic and inducing effect of corneal crosslinking on infectious keratitis | Zendy

LiangZhu Jiang | Zendy; Shiyan Qiu | Zendy; Zhiwei Li | Zendy; Xiao Zhang | Zendy; Xiangchen Tao | Zendy; Guoying Mu | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Therapeutic and inducing effect of corneal crosslinking on infectious keratitis

Author(s) -

LiangZhu Jiang,

Shiyan Qiu,

Zhiwei Li,

Xiao Zhang,

Xiangchen Tao,

Guoying Mu

Publication year - 2016

Publication title -

international journal of ophthalmology

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.634

H-Index - 29

eISSN - 2227-4898

pISSN - 2222-3959

DOI - 10.18240/ijo.2016.12.20

Subject(s) - medicine , keratitis , riboflavin , dermatology , ophthalmology , ultraviolet a , food science , chemistry

The corneal crosslinking (CXL) with riboflavin and ultraviolet-A (UVA) is a new therapy method to successfully treat infectious keratitis in clinical practice. However, there are rare reports on the complications of CXL such as the secondary keratitis. The diverse clinical outcomes on keratitis have highlighted the necessity to further evaluate the efficacy and complications of CXL. We reviewed the positive and negative reports on UVA/riboflavin related with keratitis and provided our opinion on the therapeutic and side effect of UVA/riboflavin crosslinking on keratitis.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research